Antidepressant :: US FDA proposes new warnings for antidepressant medicines
Pharmaceuticals to update the existing black box warning on antidepressants’ labeling to include warnings about increased risks of suicidal thinking and behavior, known as suicidality, in young adults ages 18 to 24 during initial treatment, proposed by US FDA.